Gene · 5889
Papers3,668
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,668
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities. | Cancers (Basel) | 2023 | 36672401 | PubTator, text mining | PubMed |
| The Contribution of Germline Pathogenic Variants in Breast Cancer Genes to Contralateral Breast Cancer Risk in BRCA1/BRCA2/PALB2-Negative Women. | Cancers (Basel) | 2023 | 36672364 | PubTator, text mining | PubMed |
| Aplastic Anemia in Triple X Syndrome. | Children (Basel) | 2023 | 36670650 | PubTator, text mining | PubMed |
| Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer. | Breast Cancer (Dove Med Press) | 2023 | 36660366 | PubTator, text mining | PubMed |
| Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance. | EMBO Mol Med | 2023 | 36652375 | PubTator, text mining | PubMed |
Occurrence of variants of unknown clinical significance in genetic testing for hereditary breast and ovarian cancer syndrome and Lynch syndrome: a literature review and analytical observational retrospective cohort study. | BMC Med Genomics | 2023 | 36647026 | PubTator, text mining | PubMed |
| Polygenic risk scores and breast cancer risk prediction. | Breast | 2023 | 36646003 | PubTator, text mining | PubMed |
| Long-term risk of cancer among the first-degree relatives of epithelial ovarian cancer patients: A cohort study with 48 years of follow up. | Acta Obstet Gynecol Scand | 2023 | 36645194 | PubTator, text mining | PubMed |
| PMS2 Pathogenic Variant in Lynch Syndrome-Associated Colorectal Cancer with Polyps. | Glob Med Genet | 2023 | 36644715 | PubTator, text mining | PubMed |
| CTP synthase 2 predicts inferior survival and mediates DNA damage response via interacting with BRCA1 in chronic lymphocytic leukemia. | Exp Hematol Oncol | 2023 | 36635772 | PubTator, text mining | PubMed |
| Cancer Risk Associated With PTEN Pathogenic Variants Identified Using Multigene Hereditary Cancer Panel Testing. | JCO Precis Oncol | 2023 | 36634299 | PubTator, text mining | PubMed |
| Profiling of the genetic features of Chinese patients with gastric cancer with HRD germline mutations in a large-scale retrospective study. | J Med Genet | 2023 | 36627197 | PubTator, text mining | PubMed |
| Pulmonary artery embolism: comprehensive transcriptomic analysis in understanding the pathogenic mechanisms of the disease. | BMC Genomics | 2023 | 36624378 | PubTator, text mining | PubMed |
| Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer. | JCO Precis Oncol | 2023 | 36623239 | PubTator, text mining | PubMed |
Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study. | Ann Hematol | 2023 | 36622392 | PubTator, text mining | PubMed |
| Clinical application of PARP inhibitors in ovarian cancer: from molecular mechanisms to the current status. | J Ovarian Res | 2023 | 36611214 | PubTator, text mining | PubMed |
| Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis. | Nat Commun | 2023 | 36604421 | PubTator, text mining | PubMed |
| The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations. | Nat Cancer | 2023 | 36585449 | PubTator, text mining | PubMed |
| Functional analysis of germline RAD51C missense variants highlight the role of RAD51C in replication fork protection. | Hum Mol Genet | 2023 | 36562461 | PubTator, text mining | PubMed |
| Clinical utility of liquid biopsy and integrative genomic profiling in early-stage and oligometastatic cancer patients treated with radiotherapy. | Br J Cancer | 2023 | 36550207 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5889/papers?page=35